Application of non-myeloablative allogeneic stem cell transplantation to solid tumors

Research output: Contribution to journalArticle

Abstract

In contrast to conventional stem cell transplantation which utilizes high-dose chemotherapy and/or total body irradiation as a conditioning regimen, non-myeloablative stem cell transplantation (NST) uses mainly immunosuppressants. NST is now being used to treat solid tumors, as it greatly alleviates regimen-related toxicity. NST, which utilizes the graft-versus-tumor effect as an anti-tumor weapon, is considered to be one type of immunotherapy. Ongoing clinical studies in the U.S. and Europe as well as in Japan are producing promising results for renal cell carcinoma and other tumors.

Original languageEnglish (US)
Pages (from-to)461-466
Number of pages6
JournalBiotherapy
Volume15
Issue number4
StatePublished - 2001

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Application of non-myeloablative allogeneic stem cell transplantation to solid tumors'. Together they form a unique fingerprint.

  • Cite this